Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3D2U

Structure of UL18, a Peptide-Binding Viral MHC Mimic, Bound to a Host Inhibitory Receptor

Summary for 3D2U
Entry DOI10.2210/pdb3d2u/pdb
DescriptorUL18 protein, Beta-2-microglobulin, Leukocyte immunoglobulin-like receptor subfamily B member 1, ... (9 entities in total)
Functional Keywordsmhc class i homolog, disease mutation, glycation, glycoprotein, immune response, immunoglobulin domain, mhc i, pyrrolidone carboxylic acid, secreted, membrane, phosphoprotein, receptor, transmembrane, immune system
Biological sourceHuman herpesvirus 5 (Human cytomegalovirus)
More
Total number of polymer chains8
Total formula weight136348.39
Authors
Yang, Z.,Bjorkman, P.J. (deposition date: 2008-05-08, release date: 2008-07-08, Last modification date: 2024-11-20)
Primary citationYang, Z.,Bjorkman, P.J.
Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor
Proc.Natl.Acad.Sci.Usa, 105:10095-10100, 2008
Cited by
PubMed Abstract: UL18 is a human cytomegalovirus class I MHC (MHCI) homolog that binds the host inhibitory receptor LIR-1 and the only known viral MHC homolog that presents peptides. The 2.2-A structure of a LIR-1/UL18/peptide complex reveals increased contacts and optimal surface complementarity in the LIR-1/UL18 interface compared with LIR/MHCI interfaces, resulting in a >1,000-fold higher affinity. Despite sharing only approximately 25% sequence identity, UL18's structure and peptide binding are surprisingly similar to host MHCI. The crystal structure suggests that most of the UL18 surface, except where LIR-1 and the host-derived light chain bind, is covered by carbohydrates attached to 13 potential N-glycosylation sites, thereby preventing access to bound peptide and association with most MHCI-binding proteins. The LIR-1/UL18 structure demonstrates how a viral protein evolves from its host ancestor to impede unwanted interactions while preserving and improving its receptor-binding site.
PubMed: 18632577
DOI: 10.1073/pnas.0804551105
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.21 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon